Presage, Celgene ally to identify new drug combos for solid tumor

Presage Biosciences and Celgene entered into a research alliance to find new drug combinations for solid tumors. Presage will get $5 million upfront, $8 million in equity investment plus potential future payments.

View Full Article in:

American City Business Journals · Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC